Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Enovis (ENOV)
NYSE:ENOV
Holding ENOV?
Track your performance easily
Earnings Data
Report Date
Feb 20, 2025TBA Not Confirmed
Period Ending
2024 (Q4)Consensus EPS Forecast
$0.91Last Year’s EPS
$0.79Same Quarter Last Year
Strong Buy
Based on 7 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Nov 06, 2024
|% Change Since: -0.44%
|Next Earnings Date:Feb 20, 2025
Earnings Call Sentiment|Positive
The earnings call reflects a positive trajectory with strong revenue growth and successful integration efforts, despite some market disruptions and anticipated dis-synergies impacting short-term guidance. The company's performance remains strong with expectations for future growth.Company Guidance
During the Enovis Q3 2024 earnings call, the company provided guidance indicating expected revenues of approximately $2.1 billion for the year, with a narrowed comparable revenue growth range of 5% to 5.5%. This guidance takes into account anticipated impacts from recent hurricanes and IV shortages, which have affected results in the fourth quarter. The company expects adjusted EBITDA to be between $373 million and $378 million, reflecting more than 200 basis points of margin expansion compared to the previous year. Interest expense and depreciation for the year are projected to be around $60 million and $115 million, respectively, while the adjusted earnings per share range has been raised to $2.75 to $2.80, indicating strong double-digit earnings growth. Enovis anticipates further acceleration in 2025 as integration headwinds from the Lima acquisition diminish.Record Revenue Growth
Reported revenue growth of 21% year-over-year, with 6% growth on a comparable basis. Adjusted EBITDA margins expanded by 220 basis points.
Strong Performance in Recon Segment
Recon segment delivered 57% reported global revenue growth and 9% on a comparable basis, with U.S. Recon growth at 9%.
Successful Integration and Expansion
Integration of Lima progressing well, with commercial channels aligned. Foot and Ankle business on track to surpass $100 million in revenue.
Positive Adjusted Earnings
Adjusted earnings per share increased by 30% to $0.73, with a 38% growth in adjusted EBITDA.
---
ENOV Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
ENOV Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Nov 06, 2024 | $43.31 | $46.90 | +8.29% |
| Aug 07, 2024 | $41.98 | $40.57 | -3.36% |
| May 02, 2024 | $55.40 | $52.13 | -5.90% |
| Feb 22, 2024 | $60.27 | $63.80 | +5.86% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Enovis (ENOV) report earnings?
Enovis (ENOV) is schdueled to report earning on Feb 20, 2025, TBA Not Confirmed.
What is Enovis (ENOV) earnings time?
Enovis (ENOV) earnings time is at Feb 20, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is ENOV EPS forecast?
ENOV EPS forecast for the fiscal quarter 2024 (Q4) is $0.91.
---